RxDoctor Payments Data

Marissa Howard, NP

Nurse Practitioner · Glasgow, KYNPI 1750819967

Payments from drug & device makers

$1,941in general payments, 2019–2025

Across 112 payments — averaging $17.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$359
  • Boehringer Ingelheim$301
  • Bayer$160
  • Amgen$140
  • Merck$127
  • Mylan Specialty L.p.$115
  • plus $738 from 21 others

What the payments were for

  • Food & beverage$1,941100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,941 in reported general payments places this provider in the 75th percentile of 1,918 nurse practitioner providers in Kentucky.

See all nurse practitioner providers in Kentucky

Medicare billing

Part B allowed, 2024
$16,588
Medicare patients
161
Services billed
207

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol142$115,268
VeltassaPatiromer Calcium Sorbitex21$13,989
LokelmaSodium Zirconium Cyclosilicate26$13,965
AuryxiaFerric Citrate11$13,579
EliquisApixaban14$8,127
KerendiaFinerenone12$7,569
ProsolParenteral Amino Acid 20% No.139$7,058
InvokanaCanagliflozin12$6,587
Febuxostat44$3,060
Calcium Acetate49$2,694
Sevelamer Carbonate36$2,685
Potassium Chloride60$2,176
Doxazosin Mesylate79$1,113
Hydralazine Hcl118$927
Bisoprolol Fumarate77$859

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Lokelma$359$129,233168 claims
PfizerEliquis$78$8,12714 claims
BayerKerendia$160$7,56912 claims
Johnson & JohnsonInvokana$74$6,58712 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,918 nurse practitioner providers in Kentucky.

Other nurse practitioner in Glasgow

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →